Skip to content
Screener

Glaukos GKOS Return on equity

Return on equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
25.7%-4.5pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
14%-1.3pp
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
-48.4%-6.4pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Bausch + Lomb logo
Bausch + LombBLCO
-2.7%-0.7pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-68.6%+17.0pp

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.08B+98.7%
Enterprise value$10.07B+98.2%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Calculated from Glaukos’s reported figures.

Based on trailing twelve months.

The source filing: Glaukos’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324201

FAQ

What is Glaukos's return on equity?
Glaukos (GKOS) reported return on equity of -26% in Q2 2026.
How has Glaukos's return on equity changed year-over-year?
Glaukos's return on equity decreased by 100.2% year-over-year, from -13% to -26%.
What is the long-term trend for Glaukos's return on equity?
Over 5 years (2020 to 2025), Glaukos's return on equity has grown at a 8.0% compound annual growth rate (CAGR), from -18% to -26.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Glaukos's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude